| Primary |
| Hypertension |
42.8% |
| Depression |
7.8% |
| Essential Hypertension |
6.1% |
| Atrial Fibrillation |
5.6% |
| Type 2 Diabetes Mellitus |
3.9% |
| Cough |
3.3% |
| Hyperuricaemia |
3.3% |
| Sleep Disorder |
3.3% |
| Aneurysm |
2.8% |
| Hypercholesterolaemia |
2.8% |
| Cardiac Failure |
2.2% |
| Diabetes Mellitus |
2.2% |
| Dyslipidaemia |
2.2% |
| Blood Pressure |
1.7% |
| Blood Triglycerides Increased |
1.7% |
| Breast Cancer |
1.7% |
| Epilepsy |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Pain |
1.7% |
| Renal Transplant |
1.7% |
|
| Vomiting |
13.0% |
| Hyponatraemia |
10.1% |
| Renal Failure |
8.7% |
| Syncope |
7.2% |
| Thrombocytopenia |
7.2% |
| Renal Impairment |
5.8% |
| Toxic Skin Eruption |
5.8% |
| Rash |
4.3% |
| Urine Sodium Decreased |
4.3% |
| Visual Disturbance |
4.3% |
| Chest Discomfort |
2.9% |
| Diabetes Mellitus |
2.9% |
| Headache |
2.9% |
| Hypotension |
2.9% |
| Myocardial Infarction |
2.9% |
| Neutropenia |
2.9% |
| Oedema |
2.9% |
| Orthostatic Hypotension |
2.9% |
| Platelet Count Increased |
2.9% |
| Respiratory Failure |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
23.7% |
| Drug Use For Unknown Indication |
21.4% |
| Cardiovascular Disorder |
17.4% |
| Hypertension |
16.3% |
| Essential Hypertension |
3.0% |
| Atrial Fibrillation |
1.7% |
| Schizophrenia, Paranoid Type |
1.7% |
| Pain |
1.6% |
| Diabetes Mellitus |
1.4% |
| Partial Seizures |
1.3% |
| Type 2 Diabetes Mellitus |
1.3% |
| Back Pain |
1.1% |
| Coronary Artery Disease |
1.1% |
| Depression |
1.1% |
| Heart Transplant |
1.1% |
| Parkinson's Disease |
1.1% |
| Breast Cancer |
1.0% |
| Cardiac Failure |
1.0% |
| Epilepsy |
1.0% |
| Dementia Alzheimer's Type |
0.8% |
|
| Renal Failure Acute |
9.3% |
| Hyponatraemia |
7.9% |
| Renal Failure |
7.9% |
| Thrombocytopenia |
7.9% |
| Electrocardiogram Qt Prolonged |
7.1% |
| Bone Marrow Failure |
6.4% |
| Bradycardia |
5.0% |
| Psychomotor Retardation |
5.0% |
| Syncope |
5.0% |
| Hypotension |
4.3% |
| Pruritus |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| Abdominal Pain |
3.6% |
| Orthostatic Hypotension |
3.6% |
| Portal Hypertension |
3.6% |
| Pruritus Generalised |
3.6% |
| Decreased Appetite |
2.9% |
| Eosinophilia |
2.9% |
| Overdose |
2.9% |
| Platelet Count Increased |
2.9% |
|
| Concomitant |
| Hypertension |
23.4% |
| Product Used For Unknown Indication |
17.9% |
| Drug Use For Unknown Indication |
17.7% |
| Atrial Fibrillation |
4.7% |
| Prophylaxis |
4.3% |
| Rheumatoid Arthritis |
3.9% |
| Diabetes Mellitus |
3.1% |
| Multiple Myeloma |
2.9% |
| Depression |
2.8% |
| Type 2 Diabetes Mellitus |
2.4% |
| Bronchitis |
2.0% |
| Pain |
2.0% |
| Osteoporosis |
1.8% |
| Hypercholesterolaemia |
1.6% |
| Rectal Cancer |
1.6% |
| Coronary Artery Disease |
1.6% |
| Thrombosis Prophylaxis |
1.6% |
| Unevaluable Event |
1.6% |
| B-cell Lymphoma |
1.5% |
| Breast Cancer |
1.5% |
|
| Vomiting |
12.8% |
| Renal Failure Acute |
11.1% |
| Thrombocytopenia |
6.1% |
| Syncope |
5.6% |
| Therapeutic Agent Toxicity |
5.6% |
| Toxic Skin Eruption |
5.0% |
| Weight Increased |
5.0% |
| Haematoma |
4.4% |
| Pulmonary Embolism |
4.4% |
| Pyrexia |
4.4% |
| Hypertensive Crisis |
3.9% |
| Renal Cancer |
3.9% |
| Rhabdomyolysis |
3.9% |
| Urethral Haemorrhage |
3.9% |
| Drug Interaction |
3.3% |
| Eczema |
3.3% |
| Fall |
3.3% |
| Gamma-glutamyltransferase Increased |
3.3% |
| International Normalised Ratio Increased |
3.3% |
| Osteonecrosis |
3.3% |
|
| Interacting |
| Hypertension |
39.7% |
| Back Pain |
20.7% |
| Partial Seizures |
10.3% |
| Atrial Fibrillation |
8.6% |
| Cardiac Failure |
6.9% |
| Depression |
5.2% |
| Type 2 Diabetes Mellitus |
3.4% |
| Hypercholesterolaemia |
1.7% |
| Prophylaxis |
1.7% |
| Tachycardia |
1.7% |
|
| Drug Interaction |
17.6% |
| Hyponatraemia |
17.6% |
| Fall |
11.8% |
| Hypotension |
11.8% |
| Renal Failure Acute |
11.8% |
| Dehydration |
5.9% |
| Gait Disturbance |
5.9% |
| Laceration |
5.9% |
| Malaise |
5.9% |
| Orthostatic Hypotension |
5.9% |
|
